- Report
- March 2025
- 150 Pages
Global
From €4531EUR$4,850USD£3,833GBP
- Report
- February 2024
- 120 Pages
Global
From €4438EUR$4,750USD£3,754GBP
- Report
- May 2024
- 68 Pages
China
From €1023EUR$1,095USD£865GBP
The Pharmaceutical Raw Material market is a subset of the Pharmaceutical Intermediates market, which encompasses the production of active pharmaceutical ingredients (APIs) and other chemical compounds used in the manufacture of pharmaceuticals. Pharmaceutical Raw Materials are the basic building blocks of APIs, and include organic and inorganic compounds, such as solvents, acids, bases, and catalysts. These materials are used in the production of APIs, which are then used to manufacture finished pharmaceutical products.
The Pharmaceutical Raw Material market is highly regulated, with stringent quality control measures in place to ensure the safety and efficacy of the final product. The market is also highly competitive, with a wide range of suppliers offering a variety of products.
Some of the major players in the Pharmaceutical Raw Material market include Merck KGaA, BASF, Lonza, Evonik Industries, and Solvay. Show Less Read more